Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2008

01-05-2008

Autoimmunity in Severe Combined Immunodeficiency (SCID): Lessons from Patients and Experimental Models

Authors: Joshua D. Milner, Anders Fasth, Amos Etzioni

Published in: Journal of Clinical Immunology | Special Issue 1/2008

Login to get access

Abstract

Autoimmunity is observed in many immunodeficiencies and is thought to be mediated mainly by persistent infection. Severe combined immunodeficiency (SCID) is the most severe form of immunodeficiency and is also on occasion associated with autoimmune phenomena, usually in the form of the Omenn’s Syndrome phenotype. Recent studies both in human and mice shed light into the pathogenesis of these two seemingly different conditions occurring together. Central tolerance, which is in charge of elimination of autoreactive T-cell clones, is defective in SCID because of markedly reduced expression of Aire, a transcriptional regulator for the expression of tissue-specific antigens in the thymus. Peripheral tolerance is also markedly decreased in SCID because of several factors including the expansion of T-cell clones as a consequence of the lymphopenia observed in these condition as well as a diminished number of T regulatory (FOXP3+)cells, allowing autoreactive T cells to proliferate and infiltrate various organs in the body of SCID. It is thus of no surprise when both central and peripheral tolerance are impaired that autoimmunity can be observed in SCID.
Literature
1.
go back to reference Palmer K, Green TD, Roberts JL, et al. Unusual clinical and immunological manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allerg Clin Immunol 2007;120:423–8.CrossRef Palmer K, Green TD, Roberts JL, et al. Unusual clinical and immunological manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allerg Clin Immunol 2007;120:423–8.CrossRef
2.
go back to reference Elhasid R, Bergman R, Etzioni A. Autoimmunity in severe combined immunodeficiency. Blood 2002;100:2677–8.PubMedCrossRef Elhasid R, Bergman R, Etzioni A. Autoimmunity in severe combined immunodeficiency. Blood 2002;100:2677–8.PubMedCrossRef
3.
go back to reference Honig M, Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheum 2006;268:383–8.CrossRef Honig M, Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheum 2006;268:383–8.CrossRef
4.
go back to reference Villa A, Santagata S, Bozzi F, et al. Partial V(D) J recombination activity leads to Omenn Syndrome. Cell 1998;93:885–96.PubMedCrossRef Villa A, Santagata S, Bozzi F, et al. Partial V(D) J recombination activity leads to Omenn Syndrome. Cell 1998;93:885–96.PubMedCrossRef
5.
6.
go back to reference Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002;99:2694–702.PubMedCrossRef Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002;99:2694–702.PubMedCrossRef
7.
go back to reference Dalal I, Tabori V, Bielorai B, et al. Evolution of T-B-SCID into an Omenn syndrome phenotype following para-influenza 3 virus infection. Clin Immunol 2005;115:70–3.PubMedCrossRef Dalal I, Tabori V, Bielorai B, et al. Evolution of T-B-SCID into an Omenn syndrome phenotype following para-influenza 3 virus infection. Clin Immunol 2005;115:70–3.PubMedCrossRef
9.
go back to reference Gollagos AM, Bevan UJ. Central tolerance: good but imperfect. Immunol Rev 2006;209:290–6.CrossRef Gollagos AM, Bevan UJ. Central tolerance: good but imperfect. Immunol Rev 2006;209:290–6.CrossRef
11.
go back to reference Marella U, Poliani PL, Casati A, RUcci R, Frascoli L, Gougeon ML, et al. A lypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 2007;117:1260–9.CrossRef Marella U, Poliani PL, Casati A, RUcci R, Frascoli L, Gougeon ML, et al. A lypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 2007;117:1260–9.CrossRef
12.
go back to reference Cavadini P, Vermi W, Faccheti F, Fontana S, Magafuchi S, Mazzolari E, et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005;115:728–32.PubMed Cavadini P, Vermi W, Faccheti F, Fontana S, Magafuchi S, Mazzolari E, et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005;115:728–32.PubMed
13.
go back to reference Notarangelo LD, Gambineri E, Badolato R. Immunodeficiencies with autoimmune consequences. Adv Immunol 2006;89:321–70.PubMedCrossRef Notarangelo LD, Gambineri E, Badolato R. Immunodeficiencies with autoimmune consequences. Adv Immunol 2006;89:321–70.PubMedCrossRef
14.
go back to reference Kieper WC, Troy A, Burghardt JT, Ramsey C, Lee JY, Jiang HQ, et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 2005;174:3158–63.PubMed Kieper WC, Troy A, Burghardt JT, Ramsey C, Lee JY, Jiang HQ, et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 2005;174:3158–63.PubMed
15.
go back to reference Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365–71.PubMedCrossRef Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365–71.PubMedCrossRef
16.
go back to reference Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131:33–45.PubMedCrossRef Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131:33–45.PubMedCrossRef
17.
go back to reference Khiong K, Murakami M, Kitabayashi C, Ueda N, Sawa S, Sakamoto A, et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest 2007;117:1270–81.PubMedCrossRef Khiong K, Murakami M, Kitabayashi C, Ueda N, Sawa S, Sakamoto A, et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest 2007;117:1270–81.PubMedCrossRef
18.
go back to reference Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007;8:191–7.PubMedCrossRef Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007;8:191–7.PubMedCrossRef
19.
go back to reference Milner JD, Ward JM, Keane-Myers A, Paul WE. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci U S A 2007;104:576–81.PubMedCrossRef Milner JD, Ward JM, Keane-Myers A, Paul WE. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci U S A 2007;104:576–81.PubMedCrossRef
20.
go back to reference Candotti F, Notarangelo LD, Visconti R, O’Shea J. Molecular aspects of primary immunodeficiencies lessons from cytokines and other signaling pathways. J Clin Invest 2002;109:1261–9.PubMed Candotti F, Notarangelo LD, Visconti R, O’Shea J. Molecular aspects of primary immunodeficiencies lessons from cytokines and other signaling pathways. J Clin Invest 2002;109:1261–9.PubMed
Metadata
Title
Autoimmunity in Severe Combined Immunodeficiency (SCID): Lessons from Patients and Experimental Models
Authors
Joshua D. Milner
Anders Fasth
Amos Etzioni
Publication date
01-05-2008
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue Special Issue 1/2008
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-007-9159-y

Other articles of this Special Issue 1/2008

Journal of Clinical Immunology 1/2008 Go to the issue